Institutional investors purchased a net $3.2 million shares of SGMO during the quarter ended December 2015 and now own 71.46% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM LUXEMBOURG SA Bought 200.0 Thousand shares of Sangamo BioSciences Inc